POLICY PERSPECTIVE Liver diseases affect a wide range of people spanning a plethora of ages, genders, socio-economic statuses, and ethnicities. To ensure this diverse population is represented, it...
The Power of Advocacy
read more
Global Liver Institute
Donna Cryer
Donna R. Cryer, JD is Founder, President and Chief Executive Officer of Global Liver Institute, the only patient-driven liver health nonprofit operating across the US, EU, and UK. GLI convenes the NASH, Liver Cancer and Pediatric and Rare Liver Disease Councils, as well as the Liver Action Network, collectively more than 200 organizations.
Patient-Driven Transformation is Key to NASH Clinical Trials
There is not a day that passes that I do not receive a call to help recruit for a clinical trial. The efforts to reach out to patients seem ad hoc, scattershot, and an afterthought to rescue...
Q&A on a Third Vaccine Dose for Immunocompromised Individuals
The Global Liver Institute (GLI) has been consistent, since March 2020, in advocating for the prioritization of liver patients, cancer patients, transplant recipients, and those with compromised...
Global Liver Institute Applauds FDA and CDC Actions to Approve Third COVID-19 Vaccine Dose for Immunocompromised Individuals
(Washington, D.C., Friday, August 13, 2021)—Global Liver Institute (GLI) CEO and President Donna R. Cryer, JD, today applauded dual actions from U.S. government health agencies: U.S. Food and Drug...
Prioritizing Liver Health in ARPA-H
POLICY PERSPECTIVE Recently, Global Liver Institute (GLI) sent a letter to U.S. Representatives Diana DeGette and Fred Upton in response to their request for stakeholder input on the development of...
GLI Response to Updated Organ Transplant Societies’ Statement on Vaccine Efficacy in Transplant Recipients
Global Liver Institute has consistently advocated for a more muscular and proactive set of solutions for transplant recipients, cancer patients, and individuals with compromised immune systems...
Global Liver Institute Urges FDA to Approve COVID-19 Booster Vaccines for Transplant Recipients
(Washington, D.C., Monday, July 26, 2021)—Global Liver Institute (GLI) today urged the U.S. Food and Drug Administration to expedite the review of growing safety and effectiveness data and approve...
Global Liver Institute Urges OMB to Help Reform Organ Transplantation System That Creates and Perpetuates Inequities for People of Color
(Washington, D.C., Thursday, July 15, 2021)—Global Liver Institute (GLI) is urging the U.S. Office of Management and Budget (OMB) to implement fixes to the organ transplantation system rife with...
GLI Welcomes Prominent International Patient Advocate as Patient Insights Director
(Washington, D.C., Wednesday, July 7, 2021)—Global Liver Institute (GLI) today announced the hiring of Robert Mitchell-Thain, a prominent international patient advocate, to the newly created...
The Expansion of the Liver Action Network
POLICY PERSPECTIVE Just recently Global Liver Institute (GLI) proudly announced the expansion of the Liver Action Network (LAN) to include collaborations with the Liver Coalition of San Diego, the...
Recent News
Congress debates appropriations and other end-of-year legislation. Biden administration issues more rulemakings. Agencies prepare for new leadership. – Liver Health Policy Update
Congress debates appropriations and other end-of-year legislation. Biden administration issues more rulemakings. Agencies prepare for new leadership. Members of Congress have returned to Washington, DC. It is unclear if many healthcare priorities will make it to final...
The Most Common Chronic Liver Disease in the World – Fatty Liver Disease News
The Most Common Chronic Liver Disease in the WorldGlobal Liver Institute on the Road Last month, the GLI team proudly attended AASLD's The Liver Meeting™, starting with our 10th anniversary celebration, which brought together patient advocates, industry leaders, and...
Global Liver Institute’s Statement on Centers for Medicare & Medicaid Services Obesity Coverage Proposed Rule
Global Liver Institute’s Statement on Centers for Medicare & Medicaid Services Obesity Coverage Proposed RuleGlobal Liver Institute is thrilled to share that the Centers for Medicare & Medicaid Services (CMS) has proposed to align coverage policy to reflect...
Healthy Holidays! Gut Friendly Tips and Liver Health Innovations – Liver Cancer News
Healthy Holidays! Gut Friendly Tips and Liver Health Innovations Welcome to this special holiday edition of Liver Cancer News! As the festive season begins, read on to discover articles on liver cancer health, the latest management tools, and recent innovations. In...
Global Liver Institute Acknowledges FDA Request for Further Studies as Obeticholic Acid Remains Available for PBC Patients
Global Liver Institute Acknowledges FDA Request for Further Studies as Obeticholic Acid Remains Available for PBC Patients(Washington, D.C. November 12, 2024) – Global Liver Institute (GLI) acknowledges the U.S. Food and Drug Administration’s (FDA) decision today to...